Solesence (NASDAQ:SLSN) Trading Down 3.1% - Should You Sell?

Key Points

• Solesence shares fell 3.1% to $1.11 on Friday with volume of 20,847 shares (about a 55% decline from average), trading below its 50-day ($1.17) and well below its 200-day ($2.01) moving averages.
• Analyst sentiment is negative: Weiss Ratings reaffirmed a "Sell (d)" and the stock's average rating on MarketBeat is "Sell."
• The company has a market cap of $78.4M and a high PE of 55.5, with a quick ratio of 0.74 (potential short-term liquidity concern) and roughly 70.22% institutional ownership, though recent institutional purchases were small dollar stakes.

Solesence, Inc. (NASDAQ:SLSN - Get Free Report)'s share price traded down 3.1% during mid-day trading on Friday . The stock traded as low as $1.10 and last traded at $1.11. 20,847 shares were traded during trading, a decline of 55% from the average session volume of 46,354 shares. The stock had previously closed at $1.1450.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Solesence in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of "Sell".

Solesence Trading Down 3.1%

The business's fifty day moving average is $1.17 and its 200-day moving average is $2.01. The stock has a market capitalization of $78.40 million, a PE ratio of 55.53 and a beta of 1.17. The company has a quick ratio of 0.74, a current ratio of 2.07 and a debt-to-equity ratio of 0.60.

Institutional Investors Weigh In On Solesence

Institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE purchased a new stake in Solesence in the second quarter valued at approximately $26,000. JPMorgan Chase & Co. acquired a new position in Solesence during the second quarter valued at approximately $39,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Solesence during the second quarter valued at approximately $45,000. Goldman Sachs Group Inc. acquired a new position in Solesence during the fourth quarter valued at approximately $30,000. Finally, New York State Common Retirement Fund acquired a new position in Solesence during the second quarter valued at approximately $95,000. 70.22% of the stock is currently owned by hedge funds and other institutional investors.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.